Menopause Drug Breakthrough

A brand new concept in menopausal therapy is going to be available. Thanks to years of hard work by the Clinical Trial Principal Investigators, and the participants in the hot flash and osteoporosis trails, including our clinical team and patients at Women's Health Practice those who participated in the medication that became Duavee. Food and Drug Administration (FDA) today approved a novel estrogen-based drug for women to treat moderate-to-severe vasomotor symptoms associated with menopause as well as prevent postmenopausal osteoporosis, the agency said today. The new drug for menopausal women (Duavee, Wyeth Pharmaceuticals, a division of Pfizer) is the first to combine conjugated estrogens with bazedoxifene, an estrogen agonist/antagonist. For optimizing women's health in menopausal years, individual care is important understanding what you are most at risk for and what symptoms you have.


Popular posts from this blog

Passing Your Uterine Lining, Menstrual Period Norms

Mirena IUD and Your Sex Drive

Post-Endometrial Ablation Syndrome